A&

Amines & Plasticizers Ltd

Q1 FY27Chemicals & Petrochemicals

Amines & Plasticizers Ltd Q1 FY27 Results & Presentation Highlights: Revenue ₹150.53 Cr, EBITDA margin 10.06%

Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.

Price₹163
Market cap₹944 Cr
P/E24.5
Updated25 Sept 2026
Read4 min read

Based on Amines & Plasticizers Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Q1FY27 Revenue from Operations: ₹150.53 Crores, a 7% year-on-year increase from Q1FY26 (₹140.29 Crores). Q1FY27 Figures (₹ Crores): - EBITDA: 15.14 (↑16% YoY) - EBITDA Margin: 10.06% (↑75 bps YoY) - Net Profit (PAT): 9.47 (↑27% YoY) - Quarterly Trends: - EBITDA declined 36% QoQ f

From Amines & Plasticizers Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

  • Q1FY27 Revenue from Operations: ₹150.53 Crores, a 7% year-on-year increase from Q1FY26 (₹140.29 Crores).
  • Total Income for Q1FY27: ₹150.72 Crores, also up 7% year-on-year.
  • No specific volume figures are reported in the presentation.
  • Management Commentary notes:
  • The company entered FY27 with high inventory, aiding navigation of supply chain challenges and protecting profitability.
  • Plant operations were at partial capacity due to limited and costly fuel/gas.
  • Price increases for raw materials and finished goods were passed to customers, except for some government tenders.
  • Supplies to the Middle East paused but resumed on no-credit terms.
  • Operations have stabilized in Q2, with a firm order book supporting continued profitability.

2 more points management made on revenue & sales performance

Profitability & Margins

See what Amines & Plasticizers Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

The investor presentation does not explicitly describe any specific capex amounts, capacity expansions, or new plant/projects with detailed status or timelines. Key points related to capacity and expansion are: - The company has two integrated facilities across 56 acres, with underutilized land and capacity for modular expansions (Page 20). - Production capacities and manufacturing capabilities are detailed (Pages 9-11), but no mention of ongoing or planned capacity expansion projects or new plants. - Capital Work-in-Progress reduced from ₹0.38 Cr in FY25 to ₹0.09 Cr in FY26, indicating minimal active capex (Page 23).

2 more points management made on capital expenditure plans

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

5x potential
Rev 1Mar 2
2Yasho Industries
Rev 1Mar 3
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Amines & Plasticizers Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The presentation does not provide specific numerical details on the order book, order inflow, or pending orders.
  • Page 27 (Management Commentary) states: "Operations have stabilised in the second quarter, and we hold a firm order book that supports the continuation of current profitability."
  • It also mentions encouraging commercial developments and progression of new export opportunities.
  • Agreements with two global multinational corporations have been secured for supplying formulated solvents globally.

2 more points management made on order book & pipeline

Amines & Plasticizers Ltd — Quarterly revenue & net profit

Revenue Net profit
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹142 Cr, net profit ₹8 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Fine Organic Industries Ltd (Q1 FY27)

    Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key investor presentation takeaways from Fine

  • Chemfab Alkalis Ltd (Q1 FY27)

    Consolidated Q1FY27 Revenue from Operations:** ₹73.16 crore, down 20.08% YoY (from ₹91.54 crore in Q1FY26). Key investor presentation takeaways from Chemfab Alk

  • Gujarat Alkalies & Chemicals Ltd (Q1 FY27)

    Quarterly revenue for Q4 FY26 is INR 1,144 Cr., up from INR 1,004 Cr. Key investor presentation takeaways from Gujarat Alkalies & Chemicals Ltd's Q1 FY27 invest

  • Sudarshan Pharma Industries Ltd (Q1 FY27)

    Revenue from Operations for June 2026 quarter: ₹174.41 Cr (Page 39) . Key investor presentation takeaways from Sudarshan Pharma Industries Ltd's Q1 FY27 investo

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Amines & Plasticizers Ltd Q1 FY27 results?

Q1FY27 Revenue from Operations: ₹150.53 Crores, a 7% year-on-year increase from Q1FY26 (₹140.29 Crores). Q1FY27 Figures (₹ Crores): - EBITDA: 15.14 (↑16% YoY) - EBITDA Margin: 10.06% (↑75 bps YoY) - Net Profit (PAT): 9.47 (↑27% YoY) - Quarterly Trends: - EBITDA declined 36% QoQ f

What is Amines & Plasticizers Ltd share price analysis?

Amines & Plasticizers Ltd currently shows a neutral. The stock trades at a P/E of 24.5 with a market cap of ₹944 Cr. Investors should review the full earnings analysis for detailed insights.

Is Amines & Plasticizers Ltd planning capital expenditure?

The investor presentation does not explicitly describe any specific capex amounts, capacity expansions, or new plant/projects with detailed status or timelines.

Keep Amines & Plasticizers Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.